We are live on ! Find out more
ABBV icon

AbbVie

4,285 hedge funds and large institutions have $343B invested in AbbVie in 2026 Q3 according to their latest regulatory filings, with 216 funds opening new positions, 1,843 increasing their positions, 1,697 reducing their positions, and 99 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more first-time investments, than exits

New positions opened: 216 | Existing positions closed: 99

14% more call options, than puts

Call options by funds: $4.11B | Put options by funds: $3.62B

9% more repeat investments, than reductions

Existing positions increased: 1,843 | Existing positions reduced: 1,697

1% more funds holding

Funds holding: 4,263 → 4,285 (+22)

0% more funds holding in top 10

Funds holding in top 10: 201 → 201 (0)

1.93% less ownership

Funds ownership: 76.06% → 74.13% (-1.9%)

26% less capital inflows, than outflows

Capital inflows: $14.1B | Capital outflows: $19B

Holders
4,285
Holders Change
+22
Holders Change %
+0.52%
% of All Funds
52.08%
Holding in Top 10
201
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
2.44%
New
216
Increased
1,843
Reduced
1,697
Closed
99
Calls
$4.11​B
Puts
$3.62​B
Net Calls
+$492​M
Net Calls Change
-⁠$141​M

ABBV Hedge Fund Activity: Q3 2026 in Review

4,285 of the 8,227 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q3 2026, worth a combined $343B — up 1.6% from $338B a quarter earlier.

Buyers outnumbered sellers: 216 funds opened new ABBV positions and 99 closed out — a net gain of 117 holders — while 1,843 added to existing stakes and 1,697 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $1.45B. The largest seller was Royal Bank of Canada, cutting an estimated $2.21B.

  • 4,285 institutional investors held AbbVie (ABBV) as of Q3 2026, up from 4,263 in Q2 2026.
  • Funds reported $343B of AbbVie stock for Q3 2026, up 1.6% quarter-over-quarter.
  • 216 funds opened new AbbVie positions in Q3 2026 and 99 closed out, a net change of +117 holders.
  • The largest AbbVie buyer in Q3 2026 was Wellington Management Group, an estimated $1.45B added.
  • The largest AbbVie seller in Q3 2026 was Royal Bank of Canada, an estimated $2.21B sold.

Based on aggregated 13F filings for Q3 2026.